Search - tctmd.com

Displaying 841 - 860 of 4515

Sort: Relevancy | Date

P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER

News Conference News ESC 2022

P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER

August 29, 2022

More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF

News Conference News ESC 2022

INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF

Michael O'Riordan

August 28, 2022

Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke

News Conference News ESC 2022

Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke

August 28, 2022

ALL-HEART: Gout Drug Allopurinol No Help in CV Prevention

News Conference News ESC 2022

ALL-HEART: Gout Drug Allopurinol No Help in CV Prevention

August 27, 2022

DELIVER Results, Other Analyses Bolster SGLT2 Inhibitors Across HF Spectrum

News Conference News ESC 2022

DELIVER Results, Other Analyses Bolster SGLT2 Inhibitors Across HF Spectrum

August 27, 2022

Polypill Bests Usual Care in Patients With Recent MI: SECURE

News Conference News ESC 2022

Polypill Bests Usual Care in Patients With Recent MI: SECURE

Michael O'Riordan

August 26, 2022

TIME of Antihypertensive Dose Doesn’t Matter for CV Protection Open With no difference between nighttime and morning dosing, “patients can take their tablets whenever it’s convenient.” configuration options With no difference between nighttime and morning dosing, “patients can take their tablets whenever it’s convenient.”

News Conference News ESC 2022

TIME of Antihypertensive Dose Doesn’t Matter for CV Protection

August 26, 2022

More HF, Worse Long-term Outcomes in TAVI Patients Who Get Pacemakers

News Daily News

More HF, Worse Long-term Outcomes in TAVI Patients Who Get Pacemakers

August 24, 2022

Higher Annual TAVI Volumes Linked to Greater Use of Embolic Protection

News Daily News

Higher Annual TAVI Volumes Linked to Greater Use of Embolic Protection

August 23, 2022

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

News Daily News

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

August 23, 2022

What’s Going to Be Hot at ESC 2022?

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

August 22, 2022

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

News Daily News

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Michael O'Riordan

August 18, 2022

VTE Risk Higher With COVID-19 Than With Flu

News Daily News

VTE Risk Higher With COVID-19 Than With Flu

August 18, 2022

CV Symptoms Deserve More Attention, Quantification: AHA Statement

News Daily News

CV Symptoms Deserve More Attention, Quantification: AHA Statement

Yael L. Maxwell

August 18, 2022

Stroke, Bleeding Risks Key for Assessing Potential LAAO Benefit

News Daily News

Stroke, Bleeding Risks Key for Assessing Potential LAAO Benefit

August 17, 2022

Worse Complications After PVI in Women Highlight Research Gaps

News Daily News

Worse Complications After PVI in Women Highlight Research Gaps

August 16, 2022

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

News Daily News

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Michael O'Riordan

August 16, 2022

Salt Substitutes Could Have BP, CV Benefits Worldwide: Meta-analysis

News Daily News

Salt Substitutes Could Have BP, CV Benefits Worldwide: Meta-analysis

Yael L. Maxwell

August 16, 2022

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Michael O'Riordan

August 15, 2022

CASSISS: No Benefit of Stenting for Intracranial Stenosis

News Daily News

CASSISS: No Benefit of Stenting for Intracranial Stenosis

August 12, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.